Literature DB >> 10540208

Dendritic cells: the driving force behind autoimmunity in rheumatoid arthritis?

A R Pettit1, R Thomas.   

Abstract

Dendritic cells (DC) are likely to play a significant role in immune-mediated diseases such as autoimmunity and allergy. To date there are few treatments capable of inducing permanent remission in rheumatoid arthritis (RA) and elucidation of the role of DC may provide specific strategies for disease intervention. Dendritic cells have proven to be powerful tools for immunotherapy and investigations are under way to determine their clinical efficacy in transplantation and viral and tumour immunotherapy. The present review will focus on the current view of DC and their role in autoimmunity, in particular RA. Two possible roles for DC in the pathogenesis of RA will be proposed, based on recent advances in the field.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10540208     DOI: 10.1046/j.1440-1711.1999.00855.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  13 in total

1.  Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis.

Authors:  M Pashenkov; N Teleshova; M Kouwenhoven; V Kostulas; Y-M Huang; M Soderstrom; H Link
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

Review 2.  Dendritic cells, T cell tolerance and therapy of adverse immune reactions.

Authors:  P A Morel; M Feili-Hariri; P T Coates; A W Thomson
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

3.  Subcutaneous allergen immunotherapy restores human dendritic cell innate immune function.

Authors:  J R Tversky; A P Bieneman; K L Chichester; R G Hamilton; J T Schroeder
Journal:  Clin Exp Allergy       Date:  2010-01       Impact factor: 5.018

Review 4.  Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes.

Authors:  Evemie Schutyser; Ann Richmond; Jo Van Damme
Journal:  J Leukoc Biol       Date:  2005-03-22       Impact factor: 4.962

5.  Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors.

Authors:  T R D J Radstake; R van der Voort; M ten Brummelhuis; M de Waal Malefijt; M Looman; C G Figdor; W B van den Berg; P Barrera; G J Adema
Journal:  Ann Rheum Dis       Date:  2004-08-26       Impact factor: 19.103

6.  Evidence for active antigen presentation by monocyte/macrophages in response to stimulation with particles: the expression of NFκB transcription factors and costimulatory molecules.

Authors:  Huwaidha Altaf; Peter A Revell
Journal:  Inflammopharmacology       Date:  2013-05-14       Impact factor: 4.473

7.  The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function.

Authors:  Bernhard M Kirsch; Maximilian Zeyda; Karl Stuhlmeier; Johannes Grisar; Josef S Smolen; Bruno Watschinger; Thomas M Stulnig; Walter H Hörl; Gerhard J Zlabinger; Marcus D Säemann
Journal:  Arthritis Res Ther       Date:  2005-04-01       Impact factor: 5.156

8.  MLN51 and GM-CSF involvement in the proliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis.

Authors:  Jinah Jang; Dae-Seog Lim; Young-Eun Choi; Yong Jeong; Seung-Ah Yoo; Wan-Uk Kim; Yong-Soo Bae
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

9.  Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice.

Authors:  Alexei von Delwig; Catharien M U Hilkens; Daniel M Altmann; Rikard Holmdahl; John D Isaacs; Clifford V Harding; Helen Robertson; Norman McKie; John H Robinson
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

10.  Recruitment of dendritic cells and macrophages during T cell-mediated synovial inflammation.

Authors:  Mahin Moghaddami; Leslie G Cleland; Gorjana Radisic; Graham Mayrhofer
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.